Device Center Director Schultz Floats User Fees For Postmarket Efforts
This article was originally published in The Gray Sheet
Executive Summary
FDA is considering proposing that device user fees help fund postmarket as well as premarket activities, according to CDRH Director Dan Schultz
You may also be interested in...
Postmarket User Fees Floated At House Subcommittee Hearing
The chairman of the House subcommittee overseeing reauthorization of medical device user fees is signaling that he might push to have a portion of industry-provided funds specifically allocated for FDA postmarket activities
Postmarket User Fees Floated At House Subcommittee Hearing
The chairman of the House subcommittee overseeing reauthorization of medical device user fees is signaling that he might push to have a portion of industry-provided funds specifically allocated for FDA postmarket activities
FDA Unveils Medical Device “Postmarket Transformation”
FDA's device center is establishing a senior-level team of agency staffers and outside experts to lead an effort to revitalize the postmarket device safety program, the agency announced Jan. 19